Xconomy: The Future of Big Data: Agenda


	October 24, 2012	AGENDA

	12:30 – 1:20	Registration
	1:20 – 1:30	Welcome Sean Belka, SVP, Director, Fidelity Center for Applied Technology Greg Huang, National IT Editor and Editor, Xconomy Boston
	1:30 – 2:00	Opening Keynote Brad Feld, Managing Director, Foundry Group
	2:00-2:25	Chat: Enterprise Big Data Narayanan Krishnakumar, Chief IT Architect, EMC Burt Kaliski, CTO, VeriSign Shilpa Lawande, VP of Software Engineering & Customer Support, HP/Vertica Moderator: Greg Huang, Xconomy
	2:25-2:50	Keynote Talk David Friend, CEO, Carbonite
	2:50-3:15	Startup Panel 1: How to Use Big Data Zeid Barakat, Chief Strategy Officer, Flyberry Capital Fred Lalonde, CEO, Hopper Jennifer Lum, President, Adelphic Mobile Jay Meattle, CEO, Shareaholic Moderator: Richard Dale, Managing Director, Big Data Boston Ventures
	3:15-3:45	Networking break
	3:45-4:05	Keynote Talk Peter Stern, CEO, Bitly
	4:05-4:30	Investor Chat Ric Fulop, General Partner, North Bridge Venture Partners Rich Levandov, Managing Director, Avalon Ventures Chris Lynch, Partner, Atlas Venture Moderator: Doug Levin, CEO, Quant5
	4:30-5:00	Startup Panel 2: Big Data Infrastructure Amrith Kumar, CTO, ParElastic Barry Morris, CEO, NuoDB Andy Palmer, Board Member, Cloudant; Co-Founder, Vertica Brian Reagan, VP of Product Strategy, Actifio Emil Sit, Technical Lead, Hadapt Moderator: Matt Fates, Ascent Venture Partners
	5:00-5:05	Burst Presentation Abby Fichtner, Executive Director, hack/reduce
	5:05-5:30	Startup Panel 3: Who Wins in Big Data? Christopher Ahlberg, CEO, Recorded Future Phil Beauregard, CEO, Objective Logistics Hardi Meybaum, CEO, GrabCAD Sravish Sridhar, CEO, Kinvey Moderator: Greg Huang, Xconomy
	5:30-6:30	Networking Reception


REGISTER NOW: xconomyforum52.eventbrite.com

Xconomy Boston

Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates

Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto

Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?

John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22

As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly

Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned

Healthcare AI Tech is Here, Now We Must Learn to Manage the Data

Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption

Gerry Hays

Bart Lorang

Bill McKeon

Alfred Spector

David Johnson

Andy Sack

Alan McGlade

Ben Elowitz

Xcelerating Life Sciences San Diego

Underwriters and Partners

Xconomy on Demand

Did you miss something? Don't despair…

Underwriters and Partners

Connect with Xconomy

Xconomy on Demand